View in EDS

Common genetic modifiers influence cardiomyopathy susceptibility among the carriers of rare pathogenic variants.

Saved in:
Bibliographic Details
Title: Common genetic modifiers influence cardiomyopathy susceptibility among the carriers of rare pathogenic variants.
Authors: Klasfeld SJ; Internal Medicine Research Unit, Pfizer Research and Development, Cambridge, MA 02139, USA; Rare Disease Research Unit, Pfizer Research and Development, Cambridge, MA 02139, USA., Knutson KA; Clinical Omics and Biomarker Statistics, Pfizer Research and Development, Cambridge, MA 02139, USA., Miller MR; Internal Medicine Research Unit, Pfizer Research and Development, Cambridge, MA 02139, USA., Fauman EB; Internal Medicine Research Unit, Pfizer Research and Development, Cambridge, MA 02139, USA., Berghout J; Rare Disease Research Unit, Pfizer Research and Development, Cambridge, MA 02139, USA., Moccia R; Rare Disease Research Unit, Pfizer Research and Development, Cambridge, MA 02139, USA; Machine Learning and Computational Sciences, Pfizer Research and Development, Cambridge, MA 02139, USA. Electronic address: robert.moccia@pfizer.com., Kim HI; Internal Medicine Research Unit, Pfizer Research and Development, Cambridge, MA 02139, USA. Electronic address: hyein.kim@pfizer.com.
Source: HGG advances [HGG Adv] 2025 Jul 10; Vol. 6 (3), pp. 100460. Date of Electronic Publication: 2025 May 22.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101772885 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-2477 (Electronic) Linking ISSN: 26662477 NLM ISO Abbreviation: HGG Adv Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2666-2477
DOI:10.1016/j.xhgg.2025.100460